A standalone micro biochip to monitor the cancer progression by measuring cancer antigens as a point-of-care (POC) device for enhanced cancer management

Bharath Babu Nunna, Debdyuti Mandal, Shiqiang Zhuang, Eon Soo Lee

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Scopus citations

Abstract

FDA has approved the cancer biomarkers like CA-125 (Cancer Antigen-125), HE4 (Human Epididymis Protein 4), PSA (Prostate Specific Antigen) etc., to monitor the cancer progression by measuring the concentration levels of biomarkers in the biofluid samples of the patients. This research paper explains the detection process of the Cancer Antigens-CA 125 from a micro volume of the biofluid sample. The biochip is incorporated with the sensing platform in a microfluidic channel to detect the cancer antigens during the biofluid flow in the microchannel. The sensing platform is designed with multiple layers, in order to enhance the antibody immobilization on nano circuit and thus the detection signal. The antigen-antibody interaction during the biofluid flow on the immobilized antibodies in the microchannel change the capacitance measurements in the sensing circuit. The change in the capacitance indicates the targeted cancer antigens concentration in the biofluid sample. The concentration of CA-125 antigens used in the experiment is 55ug/ml at a pH of 7.4, in order to establish the functionality of the biochip. The change in capacitance after the antigen-antibody interaction is 679.62 pF is when compared to the bare electrodes. The In-situ realtime measurement of cancer biomarkers from a finger prick blood sample in a simple and easy way using the micro biochip helps to monitor the cancer progression more easily and thus enable the enhanced cancer management.

Original languageEnglish (US)
Title of host publication2017 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2017
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages212-215
Number of pages4
ISBN (Electronic)9781538613924
DOIs
StatePublished - Dec 19 2017
Event2017 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2017 - Bethesda, United States
Duration: Nov 6 2017Nov 8 2017

Publication series

Name2017 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2017
Volume2017-December

Other

Other2017 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2017
CountryUnited States
CityBethesda
Period11/6/1711/8/17

All Science Journal Classification (ASJC) codes

  • Health Informatics
  • Instrumentation
  • Health(social science)
  • Biomedical Engineering

Keywords

  • biochip
  • cancer diagnosis
  • cancer monitoring
  • nano circuit with capacitive sensing
  • point-of-care (POC)

Fingerprint Dive into the research topics of 'A standalone micro biochip to monitor the cancer progression by measuring cancer antigens as a point-of-care (POC) device for enhanced cancer management'. Together they form a unique fingerprint.

Cite this